AGÕæÈ˹ٷ½

STOCK TITAN

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Artivion (NYSE: AORT), a cardiac and vascular surgery company specializing in aortic disease, has scheduled its second quarter 2025 financial results release for Thursday, August 7, 2025, after market close.

The company will host a teleconference call and live webcast at 4:30 p.m. ET featuring CEO Pat Mackin, followed by a Q&A session. Participants can dial 862-298-0702 to join the call, with replay available at 877-660-6853 or 201-612-7415 using conference number 13754541.

The webcast and earnings press release will be accessible through the Investors section of www.artivion.com.

Artivion (NYSE: AORT), azienda specializzata in chirurgia cardiaca e vascolare focalizzata sulle patologie aortiche, ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 per giovedì 7 agosto 2025, dopo la chiusura del mercato.

L’azienda terrà una teleconferenza e una diretta web alle 16:30 ET con il CEO Pat Mackin, seguita da una sessione di domande e risposte. I partecipanti potranno chiamare il numero 862-298-0702 per unirsi alla chiamata; la registrazione sarà disponibile al numero 877-660-6853 o 201-612-7415 utilizzando il codice conferenza 13754541.

La diretta web e il comunicato stampa con i risultati saranno accessibili nella sezione Investitori del sito www.artivion.com.

Artivion (NYSE: AORT), una empresa especializada en cirugía cardíaca y vascular enfocada en enfermedades de la aorta, ha programado la publicación de sus resultados financieros del segundo trimestre de 2025 para el jueves 7 de agosto de 2025, después del cierre del mercado.

La compañía realizará una teleconferencia y una transmisión en vivo a las 4:30 p.m. ET con el CEO Pat Mackin, seguida de una sesión de preguntas y respuestas. Los participantes pueden llamar al 862-298-0702 para unirse a la llamada; la repetición estará disponible en los números 877-660-6853 o 201-612-7415 usando el número de conferencia 13754541.

La transmisión en vivo y el comunicado de prensa con los resultados estarán disponibles en la sección de Inversionistas del sitio www.artivion.com.

Artivion (NYSE: AORT)ì€ ëŒ€ë™ë§¥ 질환ì� 전문으로 하는 심장 ë°� 혈관 수술 회사ë¡�, 2025ë…� 2분기 재무 실ì ì� 2025ë…� 8ì›� 7ì� 목요ì� ìž� ë§ˆê° í›„ì— ë°œí‘œí•� 예정입니ë‹�.

회사ëŠ� CEO Pat Mackinì� 참여하는 ì „í™” íšŒì˜ ë°� ë¼ì´ë¸� 웹ìºìŠ¤íŠ¸ë¥� ë™ë¶€ 시간 오후 4ì‹� 30ë¶�ì—� 개최하며, ì´í›„ 질ì˜ì‘답 시간ì� ì´ì–´ì§‘니ë‹�. 참가ìžëŠ” 862-298-0702ë¡� ì „í™”í•� 회ì˜ì—� 참여í•� ìˆ� 있으ë©�, 재청취는 877-660-6853 ë˜ëŠ” 201-612-7415 번호ë¡� íšŒì˜ ë²ˆí˜¸ 13754541ì� 사용í•� 가능합니다.

웹ìºìŠ¤íŠ¸ì™€ ì‹¤ì  ë³´ë„ ìžë£ŒëŠ� www.artivion.comì� 투ìžìž� 섹션ì—서 확ì¸í•� ìˆ� 있습니다.

Artivion (NYSE : AORT), une entreprise spécialisée dans la chirurgie cardiaque et vasculaire axée sur les maladies de l'aorte, a prévu la publication de ses résultats financiers du deuxième trimestre 2025 pour le jeudi 7 août 2025, après la clôture du marché.

La société organisera une téléconférence et une diffusion en direct à 16h30 ET avec le PDG Pat Mackin, suivie d'une session de questions-réponses. Les participants peuvent appeler le 862-298-0702 pour rejoindre l'appel ; la rediffusion sera disponible au 877-660-6853 ou 201-612-7415 en utilisant le numéro de conférence 13754541.

La diffusion en direct et le communiqué de presse des résultats seront accessibles dans la section Investisseurs du site www.artivion.com.

Artivion (NYSE: AORT), ein auf Herz- und Gefäßchirurgie mit Schwerpunkt auf Aortenerkrankungen spezialisiertes Unternehmen, hat die Veröffentlichung der Finanzergebnisse ´Úü°ù das zweite Quartal 2025 ´Úü°ù Donnerstag, den 7. August 2025, nach Börsenschluss, geplant.

Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und einen Live-Webcast mit CEO Pat Mackin veranstalten, gefolgt von einer Fragerunde. Teilnehmer können sich unter 862-298-0702 einwählen; eine Wiederholung ist unter den Nummern 877-660-6853 oder 201-612-7415 mit der Konferenznummer 13754541 verfügbar.

Der Webcast und die Pressemitteilung mit den Ergebnissen sind im Investor-Bereich von www.artivion.com ³ú³Ü²µÃ¤²Ô²µ±ô¾±³¦³ó.

Positive
  • None.
Negative
  • None.

ATLANTA, July 24, 2025 /PRNewswire/ --ÌýArtivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced todayÌýthat second quarter 2025 financial resultsÌýwill be released on Thursday, August 7, 2025, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 862-298-0702 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13754541.Ìý

The live webcast and replay can be accessed on the Investors section of the Artivion website at and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, .

Contacts:

Artivion

Lance A. Berry

Executive Vice President &

Chief Financial Officer

Phone: 770-419-3355

GilmartinÌýGroup LLC

Brian Johnston / Laine Morgan

Phone: 332-895-3222

[email protected]

Ìý

Cision View original content to download multimedia:

SOURCE Artivion, Inc.

FAQ

When will Artivion (AORT) release its Q2 2025 earnings?

Artivion will release its Q2 2025 financial results on Thursday, August 7, 2025 after the market closes.

How can I listen to Artivion's Q2 2025 earnings call?

You can dial 862-298-0702 before 4:30 p.m. ET on August 7, 2025, or access the live webcast through the Investors section at www.artivion.com.

Who will lead Artivion's Q2 2025 earnings call?

Pat Mackin, Chairman, President and Chief Executive Officer of Artivion, will lead the earnings call and Q&A session.

How can I access the replay of Artivion's Q2 2025 earnings call?

The replay will be available by calling 877-660-6853 or 201-612-7415 with conference number 13754541, or through the Investors section at www.artivion.com.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.08B
42.17M
4.5%
89.69%
2.56%
Medical Devices
Surgical & Medical Instruments & Apparatus
United States
KENNESAW